| |
| |
|
| Insider
Information: |
Lo Steven |
| Relationship: |
President, Chief Exec ... |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
868,136 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,931,312 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
868,136 |
|
|
| Total
Value |
$13,931,312 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -185.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
SVP Oncology |
2015-11-16 |
585,416 |
2015-09-29 |
0 |
Premium* |
|
|
Puma Biotechnology Inc |
PBYI |
Chief Commercial Officer |
2019-07-22 |
19,557 |
2016-10-14 |
0 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Chief Executive Office... |
2022-06-06 |
13,163 |
2021-03-30 |
0 |
Premium* |
|
|
Vaxart Inc |
VXRT |
President, Chief Exec ... |
2024-03-18 |
250,000 |
2024-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VXRT |
Vaxart Inc |
President, Chief Exec Officer |
• • – |
2024-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
Chief Executive Officer |
• • – |
2022-06-06 |
4 |
S |
$0.71 |
$314 |
D/D |
(442) |
13,163 |
0 |
% |
|
| ZSAN |
Zosano Pharma Corp |
Chief Executive Officer |
• • – |
2022-03-31 |
4 |
S |
$0.21 |
$4,965 |
D/D |
(23,633) |
460,709 |
0 |
% |
|
| ZSAN |
Zosano Pharma Corp |
Chief Executive Officer |
• • – |
2021-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
118,750 |
484,342 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
Chief Executive Officer |
• • – |
2021-06-04 |
4 |
S |
$0.81 |
$10,592 |
D/D |
(13,158) |
365,592 |
0 |
% |
|
| ZSAN |
Zosano Pharma Corp |
Chief Executive Officer |
• • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
232,500 |
378,750 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2019-07-22 |
4 |
AS |
$10.04 |
$18,600 |
D/D |
(1,852) |
19,557 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2019-01-22 |
4 |
AS |
$24.91 |
$52,664 |
D/D |
(2,114) |
21,409 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2018-07-20 |
4 |
AS |
$51.85 |
$95,360 |
D/D |
(1,839) |
23,523 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2018-01-22 |
4 |
AS |
$92.85 |
$172,515 |
D/D |
(1,858) |
25,362 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2017-07-20 |
4 |
AS |
$94.90 |
$188,853 |
D/D |
(1,990) |
27,220 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2017-01-20 |
4 |
AS |
$33.24 |
$76,108 |
D/D |
(2,290) |
29,210 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Chief Commercial Officer |
• – – |
2016-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
31,500 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
SVP Oncology |
• – – |
2015-11-16 |
4 |
OE |
$1.92 |
$1,796,009 |
D/D |
585,416 |
585,416 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
VP Commercial Operations |
• – – |
2015-11-02 |
4 |
S |
$4.00 |
$50,000 |
D/D |
(12,500) |
0 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
VP Commercial Operations |
• – – |
2015-10-26 |
4 |
OE |
$3.29 |
$41,125 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
VP Commercial Operations |
• – – |
2015-10-13 |
4 |
S |
$3.82 |
$202,586 |
D/D |
(53,033) |
0 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
VP Commercial Operations |
• – – |
2015-10-07 |
4 |
S |
$4.00 |
$21,200 |
D/D |
(5,300) |
53,033 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
VP Commercial Operations |
• – – |
2015-10-06 |
4 |
S |
$3.76 |
$188,000 |
D/D |
(50,000) |
58,333 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
VP Commercial Operations |
• – – |
2015-09-29 |
4 |
OE |
$2.70 |
$292,499 |
D/D |
108,333 |
108,333 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
